Tombal B - Search Results

1

The Prostate Cancer gene 3 assay: indications for use in clinical practice.

Schilling D, de Reijke T, Tombal B, de la Taille A, Hennenlotter J, Stenzl A. Schilling D, et al. Among authors: tombal b. BJU Int. 2010 Feb;105(4):452-5. doi: 10.1111/j.1464-410X.2009.09085.x. Epub 2009 Nov 20. BJU Int. 2010. PMID: 19930176 Review.

2

Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.

Tombal B, De Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, Van Cangh PJ. Tombal B, et al. BJU Int. 1999 Dec;84(9):1015-20. doi: 10.1046/j.1464-410x.1999.00386.x. BJU Int. 1999. PMID: 10571626

3

Does site-specific labelling and individual processing of sextant biopsies improve the accuracy of prostate biopsy in predicting pathological stage in patients with T1c prostate cancer?

Tombal B, Tajeddine N, Cosyns JP, Feyaerts A, Opsomer R, Wese FX, Van Cangh PJ. Tombal B, et al. BJU Int. 2002 Apr;89(6):543-8. doi: 10.1046/j.1464-410x.2002.02672.x. BJU Int. 2002. PMID: 11942961

4

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.

Schröder FH, Tombal B, Miller K, Boccon-Gibod L, Shore ND, Crawford ED, Moul J, Olesen TK, Persson BE. Schröder FH, et al. Among authors: tombal b. BJU Int. 2010 Jul;106(2):182-7. doi: 10.1111/j.1464-410X.2009.08981.x. Epub 2009 Nov 13. BJU Int. 2010. PMID: 19912212 Clinical Trial.

5

Focal therapy in prostate cancer-report from a consensus panel.

de la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, Frauscher F, Greene D, Harisinghani M, Haustermans K, Heidenreich A, Kovacs G, Mason M, Montironi R, Mouraviev V, de Reijke T, Taneja S, Thuroff S, Tombal B, Trachtenberg J, Wijkstra H, Polascik T. de la Rosette J, et al. Among authors: tombal b. J Endourol. 2010 May;24(5):775-80. doi: 10.1089/end.2009.0596. J Endourol. 2010. PMID: 20477543

6

Is there a prostate-specific antigen upper limit for radical prostatectomy?

Gontero P, Spahn M, Tombal B, Bader P, Hsu CY, Marchioro G, Frea B, Van Der Eeckt K, Kneitz B, Frohneberg D, Tizzani A, Van Poppel H, Joniau S. Gontero P, et al. Among authors: tombal b. BJU Int. 2011 Oct;108(7):1093-100. doi: 10.1111/j.1464-410X.2011.10076.x. Epub 2011 Mar 10. BJU Int. 2011. PMID: 21392220

7

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion.

Tombal B, Ameye F, de la Taille A, de Reijke T, Gontero P, Haese A, Kil P, Perrin P, Remzi M, Schröder J, Speakman M, Volpe A, Meesen B, Stoevelaar H. Tombal B, et al. World J Urol. 2012 Apr;30(2):251-6. doi: 10.1007/s00345-011-0721-0. Epub 2011 Jul 1. World J Urol. 2012. PMID: 21720862

8

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H. Auprich M, et al. Among authors: tombal b. Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25. Eur Urol. 2011. PMID: 21871709 Review.

9

Testosterone in prostate cancer: the Bethesda consensus.

Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED. Djavan B, et al. Among authors: tombal b. BJU Int. 2012 Aug;110(3):344-52. doi: 10.1111/j.1464-410X.2011.10719.x. Epub 2011 Nov 30. BJU Int. 2012. PMID: 22129242 Review.

10

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups. Bolla M, et al. Among authors: tombal b. Lancet. 2012 Dec 8;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. Epub 2012 Oct 19. Lancet. 2012. PMID: 23084481 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page